63 related articles for article (PubMed ID: 1450989)
1. [Detection of the deletion of interferon-alpha and beta genes in lymphoblastoid cells by PCR].
Kita M; Tong LJ; Nakajima E; Yamada A; Sasaki O; Yamaguchi N; Kishida T; Imanishi J
C R Seances Soc Biol Fil; 1992; 186(1-2):156-63. PubMed ID: 1450989
[TBL] [Abstract][Full Text] [Related]
2. Deletions of interferon genes in acute lymphoblastic leukemia.
Diaz MO; Rubin CM; Harden A; Ziemin S; Larson RA; Le Beau MM; Rowley JD
N Engl J Med; 1990 Jan; 322(2):77-82. PubMed ID: 2294436
[TBL] [Abstract][Full Text] [Related]
3. Deletion of alpha-, beta-, and omega-interferon genes in malignant cells from children with acute lymphocytic leukemia.
Einhorn S; Grandér D; Björk O; Bröndum-Nielsen K; Söderhäll S
Cancer Res; 1990 Dec; 50(24):7781-5. PubMed ID: 1701354
[TBL] [Abstract][Full Text] [Related]
4. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
5. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia.
Coleman A; Fountain JW; Nobori T; Olopade OI; Robertson G; Housman DE; Lugo TG
Cancer Res; 1994 Jan; 54(2):344-8. PubMed ID: 8275465
[TBL] [Abstract][Full Text] [Related]
6. In acute lymphoblastic leukemia deletion of the tumor suppressor gene P16 is associated with abnormal interferon genes.
Sternik G; Pittis MG; Gutiérrez M; Diez RA; Sen L
Medicina (B Aires); 1998; 58(5 Pt 1):463-8. PubMed ID: 9922477
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
8. Action of interferon alpha and beta on four human melanoma cell lines in vitro.
Köpf J; Hanson C; Delle U; Weimarck A; Stierner U
Anticancer Res; 1996; 16(2):791-798. PubMed ID: 8687130
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas.
Otsuki T; Clark HM; Wellmann A; Jaffe ES; Raffeld M
Cancer Res; 1995 Apr; 55(7):1436-40. PubMed ID: 7882348
[TBL] [Abstract][Full Text] [Related]
11. Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the alpha-/beta-interferon genes.
Grandér D; Heyman M; Bröndum-Nielsen K; Liu Y; Lundgren E; Söderhäll S; Einhorn S
Blood; 1992 Apr; 79(8):2076-83. PubMed ID: 1562733
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to exogenously added interferon-beta protein depends on intracellular interferon-beta mRNA level in human glioma cells.
Osawa H; Mizuno M; Hatano M; Nakahara N; Tsuno T; Kuno T; Endo M; Yoshida J
Cytokine; 2005 Dec; 32(5):240-5. PubMed ID: 16343929
[TBL] [Abstract][Full Text] [Related]
13. Deletions of the short arm of chromosome 9, including the interferon-alpha/-beta genes, in acute lymphocytic leukemia. Studies on loss of heterozygosity, parental origin of deleted genes and prognosis.
Heyman M; Grandér D; Bröndum-Nielsen K; Liu Y; Söderhäll S; Einhorn S
Int J Cancer; 1993 Jul; 54(5):748-53. PubMed ID: 8100807
[TBL] [Abstract][Full Text] [Related]
14. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group.
James CD; He J; Collins VP; Allalunis-Turner MJ; Day RS
Cancer Res; 1993 Aug; 53(16):3674-6. PubMed ID: 8339274
[TBL] [Abstract][Full Text] [Related]
15. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
16. Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines.
Briggs RC; Kao WY; Dworkin LL; Briggs JA; Dessypris EN; Clark J
J Cell Biochem; 1994 Dec; 56(4):559-67. PubMed ID: 7890814
[TBL] [Abstract][Full Text] [Related]
17. Loss of FHIT expression in acute lymphoblastic leukemia.
Hallas C; Albitar M; Letofsky J; Keating MJ; Huebner K; Croce CM
Clin Cancer Res; 1999 Sep; 5(9):2409-14. PubMed ID: 10499611
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
19. Antigenic types of various human lymphoblastoid cell interferons.
Imanishi J; Hoshino S; Matsuoka H; Kishida T; Minowada J
Biken J; 1982 Jun; 25(2):97-100. PubMed ID: 6982706
[TBL] [Abstract][Full Text] [Related]
20. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
